Zeus Technologies
Country not established
- Devices
- 5
What Zeus Technologies makes
Zeus Technologies manufactures diagnostic reagents for microbiological and immunological testing, including direct fluorescent antibody conjugates for Legionella species detection, indirect fluorescent antibody reagents for Staphylococcus and Mycobacterium identification, and immunoassay reagents for estrogen measurement.
The company’s portfolio includes devices classified as Class I, Class II, and Class III under FDA regulations, with some products authorised via 510(k) clearance and others through PMA submission. These products are listed in the FDA’s regulatory databases and are intended for use in clinical and research laboratory settings.
Catalogue
Direct Fa Conjugate For Legionella Spp Ref K822859
510(k) 510(k)Veri-Staph Ref K830783
510(k) 510(k)Indirect Fluorescent Antibody Reagents Ref K831026
510(k) 510(k)Indirect Fluorescent Antibody Myco Ref K840012
510(k) 510(k)Fluoro-Cep{r} Estrogen Assay Reagent Ref P860015
PMA, withdrawn PMA
Frequently asked questions
How many devices does Zeus Technologies have in the registry?
The registry currently lists 5 devices for Zeus Technologies. Devices recorded under merged duplicate company entries are counted once.
Which registries list Zeus Technologies's devices?
Among its 5 most recently registered devices, Zeus Technologies has devices listed in FDA 510(k) (4 devices) and FDA PMA (1 device). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Zeus Technologies's devices fall under?
Among its 5 most recently registered devices, the classes recorded for Zeus Technologies's devices are Class I, Class II and Class III. Each device page shows its own class and authorisation.
What are the newest devices from Zeus Technologies in the registry?
The most recently registered devices listed for Zeus Technologies include DIRECT FA CONJUGATE FOR LEGIONELLA SPP, VERI-STAPH, INDIRECT FLUORESCENT ANTIBODY REAGENTS and INDIRECT FLUORESCENT ANTIBODY MYCO.